Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ONCOthis companyOnconetix, Inc.	$3.71	-16.49×	16.24×	313.95×	-18.91×	274.3%	77.6%	-778.2%	-1721.0%	-89.0%	-40.1%	-3.8%	0×	0.39×	-8.45×	0.66×	0.0%	1	-13.21	3	B
AZTRAzitra, Inc.	$0.66	-0.12×	0.34×	0×	0.03×	323.1%	0.0%	0.0%	0.0%	-288.2%	-259.7%	-883.5%	0.11×	0.16×	-1,445.45×	2.83×	0.0%	2	-11.55	3	B-
ENVBEnveric Biosciences, Inc.	$1.45	-0.1×	0.29×	0×	0.4×	755.2%	0.0%	0.0%	0.0%	-290.4%	-210.0%	-670.1%	0×	0.55×	-82,777.81×	5.38×	0.0%	2	-16.31	2	B-
INDPIndaptus Therapeutics, Inc.	$3.16	-0.13×	0.89×	0×	0.27×	149.5%	0.0%	0.0%	0.0%	-661.5%	-629.3%	-527.3%	0×	0.41×	0×	1.51×	0.0%	2	347.9	2	C
JSPRJasper Therapeutics, Inc.	$16.57	-0.46×	8.45×	0×	-0.1×	115.9%	0.0%	0.0%	0.0%	-1826.1%	-338.1%	-220.0%	0.3×	0.37×	0×	2.62×	0.0%	0	-45.56	2	C+
REVBRevelation Biosciences, Inc.	$4.10	-0.13×	0.22×	0×	0.88×	2467.3%	0.0%	0.0%	0.0%	-100.6%	-94.4%	-416.3%	0.08×	1.1×	0×	5.41×	0.0%	1	-11.02	2	B-
Peer median	—	-0.13×	0.34×	0×	0.27×	323.1%	0.0%	0.0%	0.0%	-290.4%	-259.7%	-527.3%	0.08×	0.41×	0×	2.83×	0.0%	2	-11.55	2	—